Zylox-Tonbridge Medical Technology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:2190 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
09 Dec 24	SellHK$1,059,015	Schroder Investment Management (Hong Kong) Ltd.	Company	96,000	HK$11.03
03 Jul 24	SellHK$30,109,254	Zhuhai Guichuang Equity Investment Center (Limited Partnership)	Company	2,509,105	HK$12.00
03 Jul 24	SellHK$11,946,694	Zhuhai Tongqiao Investment Center (Limited Partnership)	Company	995,558	HK$12.00
03 Jul 24	SellHK$13,570,653	Huzhou Guiqiao Enterprise Management Partnership (Limited Partnership)	Company	1,130,888	HK$12.00
03 Jul 24	SellHK$16,373,385	Hangzhou Fujiang Investment Partnership (Limited Partnership)	Company	1,364,449	HK$12.00
02 Jul 24	SellHK$46,906,514	AIHC Capital Management Limited	Company	3,919,000	HK$11.97

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 2190?
Owner Type	Number of Shares	Ownership Percentage
Institutions	28,207,362	8.79%
Employee Share Scheme	30,370,587	9.46%
Hedge Funds	34,401,233	10.7%
Individual Insiders	60,670,901	18.9%
VC/PE Firms	63,470,182	19.8%
General Public	103,960,261	32.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 67.53% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13%	Zhong Zhao	41,690,991	HK$462.8m	0%	no data
7.89%	OrbiMed Advisors LLC	25,335,535	HK$281.2m	0%	0.52%
6.38%	SDIC Innovation Investment Management Co., Ltd.	20,470,199	HK$227.2m	0%	1.78%
5.62%	Lake Bleu Capital (Hong Kong) Limited	18,052,991	HK$200.4m	0%	73.4%
5.5%	HighLight Capital	17,664,448	HK$196.1m	0%	40.91%
5.09%	AIHC Capital Management Limited	16,348,242	HK$181.5m	-16.8%	no data
4.41%	Schroder Investment Management (Hong Kong) Ltd.	14,157,500	HK$157.1m	-0.08%	0.12%
4.2%	Shengping Zhong	13,476,617	HK$149.6m	0%	no data
2.85%	Zhuhai Tongqiao Investment Center (Limited Partnership)	9,156,420	HK$101.6m	-9.81%	no data
2.63%	Zhuhai Guichuang Equity Investment Center (Limited Partnership)	8,449,470	HK$93.8m	-22.9%	no data
2.63%	Huzhou Guiqiao Enterprise Management Partnership (Limited Partnership)	8,446,207	HK$93.8m	-11.8%	no data
2.34%	FMR LLC	7,497,446	HK$83.2m	14.7%	no data
1.59%	Zheng Li	5,103,293	HK$56.6m	0%	no data
1.34%	Hangzhou Fujiang Investment Partnership (Limited Partnership)	4,318,490	HK$47.9m	-24%	no data
0.55%	Schroder Investment Management (Singapore) Ltd.	1,778,000	HK$19.7m	0%	0.02%
0.49%	E Fund Management Co., Ltd.	1,587,500	HK$17.6m	0%	no data
0.47%	Highlight Medical Limited	1,517,500	HK$16.8m	-66.4%	100.0%
0.12%	Yang Xie	400,000	HK$4.4m	0%	no data
0.077%	JP Morgan Asset Management	248,500	HK$2.8m	0%	no data
0.068%	BlackRock, Inc.	219,500	HK$2.4m	2.81%	no data
0.066%	Amundi Asset Management SAS	213,500	HK$2.4m	0%	no data
0.066%	Fidelity International Ltd	210,500	HK$2.3m	0%	no data
0.06%	HuaAn Fund Management Company Ltd.	192,000	HK$2.1m	0%	no data
0.051%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	162,500	HK$1.8m	0%	no data
0.043%	Dimensional Fund Advisors LP	139,416	HK$1.5m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 10:59
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zylox-Tonbridge Medical Technology Co., Ltd. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Shuo Song	Citic Securities Co., Ltd.
null null	Guoyuan Securities (HK) Ltd
Youjue Hu	Morgan Stanley